GI-Neu (Impact of colostrum-based neutraceuticals on functional gastrointestinal disorders) is an FP7-funded project, of which FAME Lab was the coordinator. The aim of this project was to develop a colostrum-based supplement to reduce endotoxemia in individuals exercising or working under hot conditions. The other partners in this project were:
– Umberto Bernabucci, Department of Agriculture, Forests, Nature and Energy, Universita Degli Studi Della Tuscia (Italy)
– Octaviu Moldovan, Imedica S.A. (Romania)
– Samim Saner, Kalite Sistem Laboratuvarlari AS (Turkey)
The programme ran from 01/10/2013 to 30/09/2017.